Trevi Therapeutics to participate in upcoming September conferences
Trevi Therapeutics says it will participate in upcoming September conferences, highlighting its investigational therapy Haduvio for chronic cough in patients with idiopathic pulmonary fibrosis and non-IPF.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.